Supplementation with lower doses of EGCg reduces liver injury markers of type 2 diabetic rats
-
- Mochizuki Kazuki
- Laboratory of Nutritional Physiology, University of Shizuoka, Graduate School of Nutritional and Environmental Sciences Faculty of Life and Environmental Sciences, University of Yamanashi
-
- Tan Yu
- Laboratory of Nutritional Physiology, University of Shizuoka, Graduate School of Nutritional and Environmental Sciences
-
- Uchiyama Yumiko
- Laboratory of Nutritional Physiology, University of Shizuoka, Graduate School of Nutritional and Environmental Sciences
-
- Suzuki Takuji
- Faculty of Education, Art and Science, Yamagata University
-
- Hariya Natsuyo
- Department of Nutrition, Faculty of Health and Nutrition, Yamanashi Gakuin University
-
- Goda Toshinao
- Laboratory of Nutritional Physiology, University of Shizuoka, Graduate School of Nutritional and Environmental Sciences
この論文をさがす
説明
<p>(-)-Epigallocatechin-3-gallate (EGCg), a major catechin in green tea, eliminates reactive oxygen species and development of lifestyle-related diseases. However, excessive EGCg intake could induce adverse effects, particularly liver injury. We examined whether optimal dietary doses of EGCg reduces the risk of liver injuries in non-obese type 2 diabetic Goto-Kakizaki (GK) rats by examining gene expression of the proinflammatory cytokines interleukin (IL)-1β, IL-18 and tumor necrosis factor-α (TNF-α) and fibrosis-related matrix metalloproteinases (MMPs) in the liver. GK rats at 9 weeks of age were fed a control high-fat diet or a high-fat diet containing 0.1%, 0.2% or 0.5% EGCg (w/w) for 25 weeks. Expression of mRNA and proteins related to inflammation were determined by qRT-PCR and western blot analysis, respectively. IL-1β and IL-18 mRNA in the liver were reduced by EGCg supplementation at concentrations of 0.1% and 0.1%-0.2%, respectively, but not at concentrations of 0.2% and 0.5% (IL-1β) or 0.5% (IL-18) EGCg. TNF-α mRNA in the liver was reduced by supplementation with EGCg at concentrations of 0.1%-0.5%. Expression of MMP2 in the liver was reduced by EGCg supplementation at a concentration of 0.2%, but not 0.1% or 0.5%. Importantly, IL-18 protein levels in the liver and serum were reduced by 0.1% EGCg, but not by 0.5%. EGCg supplementation at concentrations from 0.1% to 0.5% did not induce increases in the expression of liver injury marker genes, while low doses (0.1%–0.2%) of EGCg in GK rats reduced expression of injury-associated genes in the liver.</p>
収録刊行物
-
- Fundamental Toxicological Sciences
-
Fundamental Toxicological Sciences 6 (1), 15-23, 2019-01-30
一般社団法人 日本毒性学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390845713050946816
-
- NII論文ID
- 130007584741
-
- DOI
- 10.2131/fts.6.15
-
- ISSN
- 2189115X
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可